Monthly Archives: June 2016

Thursday 30 june 2016

Posted in Synthèse de presse | Comments closed

Ethical issues surrounding CRISPR-Cas9 technology

On 13 June last, the Inserm Ethics Committee assembled over a hundred individuals at its annual seminar. All those present had the benefit of an ethical perspective on many problems posed by biomedical research. One of the questions addressed was that of CRISPR-Cas9 technology. The Ethics Committee has devoted a specific opinion to it, while the NIH has just obtained a first green light for a human cancer immunotherapy trial.

Posted in Press releases, Genetics, genomics and bioinformatics | Tagged | Comments closed

Wednesday 29 june 2016

Posted in Synthèse de presse | Comments closed

Tuesday 28 june 2016

Posted in Synthèse de presse | Comments closed

Monday 27 june 2016

Posted in Synthèse de presse | Comments closed

Friday 24 june 2016

Posted in Synthèse de presse | Comments closed

Presentation of the French Plan for Genomic Medicine 2025

Remise du Plan Médecine Génomique 2025 à Manuel Valls

The French Plan for Genomic Medicine 2025 was presented to Prime Minister Manuel Valls by Yves Lévy, President of the National Alliance for Life Sciences and Health (Aviesan) and CEO of Inserm, on 22 June 2016.

Posted in Press releases, Institutional and special event, Health technologies | Tagged | Comments closed

Thursday 23 june 2016

Posted in Synthèse de presse | Comments closed

Wednesday 22 june 2016

Posted in Synthèse de presse | Comments closed

Tuesday 21 june 2016

Posted in Synthèse de presse | Comments closed
fermer
fermer
RSS Youtube